Interesting info: July 1, 2014 United States Myth Busters—Cholesterol and Shrimp Shrimp has long gotten a bad rap as a source of cholesterol. A three-ounce serving of shrimp has about 170 milligrams of dietary cholesterol, which is about 57% of a person’s daily recommended intake. By comparison
7.24 PM Jul 2nd
@ guest ji, u r on the dot. I m waiting for that day. Meanwhile, make hay while the sun shines. If u ve an I/d it wud have been better. Because, like good cholesterol and bad cholesterol in blood, here too, there are a couple of good guests and many......
7.57 PM Jun 18th
), Triplix (cholesterol lowering), Cymbalta (anti-depressant drug) and Zymaxid (antibacterial eye drops). Zymaxid and Triplix generics are likely to see limited competition even after the 180-day exclusivity ends. Cymbalta has seen its market share increase by 30 basis points, to 11.5%, show recent data
9.29 PM Mar 10th
Source:Bloomberg - Sun Pharma is recalling a batch of generic diabetes tablets after a customer complained of finding pills of an epilepsy medication mixed in. Separately, rival Ranbaxy pulled two batches of its version of Pfizer Inc. (PFE)'s Lipitor cholesterol-lowering
6.52 PM Mar 10th
Source:NDTV Profit - Drug maker Ranbaxy Laboratories Ltd has recalled more than 64,000 bottles of the generic versions of its cholesterol-lowering drug in the United States due to reports of a dose mix-up, US regulators said. Ranbaxy recalled tablets of atorvastatin
1.25 PM Mar 10th
Source:NDTV Profit - Mumbai: Indian drugmaker Ranbaxy Laboratories Ltd, reeling under a flurry of regulatory rebukes due to poor quality, has recalled more than 64,000 bottles of the generic version of a cholesterol-lowering drug in the United States after doseage mix-up
1.12 PM Mar 10th
Source:Bloomberg - Ranbaxy Laboratories Ltd. (RBXY), India's largest drugmaker, has recalled two batches of the company's generic version of Pfizer Inc. (PFE)'s cholesterol-lowering medicine Lipitor after a dose mix-up was detected. Ranbaxy, a unit of Tokyo-based Daiichi
1.11 PM Mar 10th
Source:NDTV Profit - Mumbai: Shares in Ranbaxy Laboratories Ltd fell as much as 3.8 per cent on Monday after the drug maker recalled more than 64,000 bottles of the generic version of a cholesterol-lowering drug in the United States after doseage mix-up was detected.
11.56 AM Mar 10th
Follow moneycontrol.comFacebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window Windows 8
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.